[In the Media] “Strengthening Response Capabilities to Infectious Diseases through Collaboration between Communities and Businesses” (The Nikkei, November 27, 2023)
date : 12/12/2023
Tags: Vaccinations
A comment by Health and Global Policy Institute (HGPI) Vice President Mr. Joji Sugawara’s comments at “Breakout Session D: Significance and Challenges of Infectious Diseases Control in Companies” held during the 10th NIKKEI FT Communicable Diseases Conference (hosted by Nikkei Inc. and co-hosted by the Financial Times) was featured in the November 27 print edition of the Nikkei.
The article addresses the fundamental contribution of immunization as a countermeasure against infectious diseases, the importance of a life-course approach to immunization policy, and the role of private companies and industries in the National Immunization Plan, based on the discussions and policy recommendations from HGPI’s immunization and vaccine policies projects.
Top Research & Recommendations Posts
Featured Posts
-
2026-08-28
[Announcement] The 3rd Kiyoshi Kurokawa Award: Call for Nominations (Deadline: November 30, 2026)
-
2026-10-06
[Registration Open] (Webinar) The 146th HGPI Seminar “How We Can Build a Society That Supports Choices Around Organ Donation: Exploring Decision-Making by Citizens and a Multi-Layered Approach Through Strategic Social Marketing” (November 9, 2026)
-
2026-10-19
[HGPI Policy Column] (No.78) — From the Blood Disorders Project “Quality of Life in Long-Term Blood Cancer Care: Insights from Canada”
-
2026-10-28
[Policy Recommendations] Driving Progress in Intractable and Rare Disease Policy Through Patient and Public Voices: Towards Redesigning Healthcare Delivery Systems Across Diagnosis (September 29, 2026)



